National Association of Testing Authorities, Australia
Scope of Accreditation
Bayside Health
Site
The Alfred Hospital Apheresis – Malignant Haematology, Transplantation and Cell Therapy Services
Accreditation No.
17137
Site No.
18733
Date of Accreditation
16 Jan 2026
Contact
Prof Andrew Spencer P: +61 (03) 90763451
Availability
Services available to external clients
Supervision
HC (Haemopoietic collection)
Scope of Accreditation
The Alfred Hospital Apheresis – Malignant Haematology, Transplantation and Cell Therapy Services
ISO 15189 (2022)
- This facility complies with the relevant National Pathology Accreditation Advisory Council (NPAAC) requirements.
Human Pathology
| Service | Product | Determinant |
|---|---|---|
| Immunopathology - Procedures related to the collection, processing, storage and issue of human haemopoietic progenitor cellsAllogeneic collection and/or processing; Autologous collection and/or processing; Product sent to the Alfred Hospital Cell Therapy Laboratory (15790-17012) | Donor lymphocytes; Haemopoietic progenitor cells | Human progenitor cell collection; MNC(A) cell collection for subsequent manufacture |
The only data displayed is that deemed relevant and necessary for the clear description of the activities and services covered by the scope of accreditation.
Grey text appearing in a SoA is additional freetext providing further refinement or information on the data in the preceding line entry.
Accreditation No.
17137
Site No.
18733
Print date
14 Mar 2026
END OF SCOPE